View Older Stories View More Recent Stories

Jun 1, 2021 06:30AM Lineage Cell Therapeutics Reports Additional Cases of Retinal Tissue Restoration in Dry AMD Patients Treated With OpRegen® RPE Cells
May 13, 2021 04:05PM Lineage Reports First Quarter 2021 Financial Results and Highlights Significant Progress With All Three Clinical Programs
May 5, 2021 08:00AM Lineage Announces Appointment of Anula Jayasuriya, M.D., PH.D., M.B.A., to Board of Directors
May 4, 2021 08:00AM Lineage Cell Therapeutics to Report First Quarter 2021 Financial Results and Provide Business Update on May 13, 2021
May 3, 2021 08:14AM Lineage Cell Therapeutics (LCTX) Announces OpRegen Clinical Data Continues to Demonstrate Improvements in Patients With Dry AMD With Geographic Atrophy
May 3, 2021 08:00AM OpRegen® Clinical Data Continues to Demonstrate Improvements in Patients With Dry AMD With Geographic Atrophy
Apr 26, 2021 08:00AM Lineage to Present at the B. Riley Securities’ Neuroscience Conference on April 28, 2021
Apr 22, 2021 08:07AM Lineage (LCTX) Announces Appointment of Dr. Dipti Amin to Its Board of Directors
Apr 22, 2021 08:00AM Lineage Announces Appointment of Dr. Dipti Amin to Its Board of Directors
Apr 20, 2021 08:03AM Lineage Cell Therapeutics (LCTX) Announces Worldwide License Agreement With Immunomic Therapeutics for Allogeneic Cell-Based Cancer Immunotherapy Based on Its VAC Platform
Apr 20, 2021 08:00AM Immunomic Therapeutics Announces License Agreement With Lineage Cell Therapeutics for Cancer Immunotherapy
Apr 20, 2021 08:00AM Lineage Announces Worldwide License Agreement With Immunomic Therapeutics for an Allogeneic Cell-Based Cancer Immunotherapy Based on Its VAC Platform
Apr 12, 2021 08:00AM OpRegen® Data Update to Be Featured at 2021 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting in Presentation by Christopher D. Riemann, MD
Mar 29, 2021 08:03AM Lineage Cell Therapeutics (LCTX) Announces Vitelliform Maculopathy Patient Treated With OpRegen® Under Named Patient Compassionate Use
Mar 29, 2021 08:00AM Lineage Cell Therapeutics Announces Vitelliform Maculopathy Patient Treated With OpRegen® Under Named Patient Compassionate Use
Mar 23, 2021 08:03AM Lineage Cell Therapeutics (LCTX) Presents Additional Interim Data on OpRegen for Dry AMD With Geographic Atrophy
Mar 23, 2021 08:00AM Lineage Cell Therapeutics Presents Additional Interim Data on OpRegen® for Dry AMD With Geographic Atrophy
Mar 17, 2021 08:00AM Lineage to Present at the Benzinga Global Biotech Small Cap Conference on March 24, 2021
Mar 11, 2021 04:05PM Lineage Cell Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update
Mar 8, 2021 08:08AM Lineage Cell Therapeutics (LCTX) Raises $35.9 Million From Sales of Marketable Securities Holdings and an At-the-Market Equity Offering
Mar 8, 2021 08:00AM Lineage Cell Therapeutics Raises $35.9 Million From Sales of Marketable Securities Holdings and an At-the-Market Equity Offering
Mar 1, 2021 08:00AM Lineage Cell Therapeutics to Report Fourth Quarter and Full Year 2020 Financial Results and Provide Business Update on March 11, 2021
Feb 23, 2021 08:00AM Lineage to Present at the Raymond James 42nd Annual Institutional Investors Conference on March 1, 2021 and the H.C. Wainwright Global Life Sciences Conference on March 9, 2021
Feb 16, 2021 08:00AM Lineage to Host Virtual OPC1 Investor & Analyst Day on February 22, 2021
Feb 8, 2021 08:00AM Lineage Enters Into Exclusive Agreement with Neurgain Technologies to Evaluate Novel Delivery System for OPC1 to Treat Spinal Cord Injury
Jan 21, 2021 08:00AM Lineage Posts Series of Webinars Highlighting Recent Progress With its Three Clinical-Stage Allogeneic Cell Transplant Programs
Jan 20, 2021 04:23PM Lineage Cell Therapeutics (LCTX) CFO to Depart
Jan 20, 2021 04:18PM Lineage Cell Therapeutics Announces Change to Executive Team
Dec 28, 2020 08:00AM Lineage Cell Therapeutics Provides End of Year Shareholder Letter
Dec 9, 2020 08:00AM Lineage Cell Therapeutics to Present at the 13th Annual LD Micro Main Event Conference on December 14, 2020
Dec 8, 2020 08:02AM Lineage Cell Therapeutics (LCTX) Provides Update on OPC1 Cell Therapy Program for the Treatment of Spinal Cord Injury
Dec 8, 2020 08:00AM Lineage Cell Therapeutics Provides Update on OPC1 Cell Therapy Program for the Treatment of Spinal Cord Injury
Nov 16, 2020 04:05PM AgeX Therapeutics Reports Third Quarter 2020 Financial Results and Provides Business Update
Nov 16, 2020 08:00AM Lineage Cell Therapeutics Presents New OpRegen® Data for Dry AMD With GA at 2020 American Academy of Ophthalmology Annual Meeting
Nov 13, 2020 08:30AM Lineage Cell Therapeutics Proudly Supports Patients’ Access to Innovative Cell Therapy Treatments and Research Through Passage of Proposition 14
Nov 11, 2020 08:00AM Lineage Cell Therapeutics Completes Patient Enrollment in Phase 1/2a Clinical Study of OpRegen® Cell Therapy for the Treatment of Dry Age-related Macular Degeneration
Nov 4, 2020 04:05PM Lineage Cell Therapeutics Reports Third Quarter 2020 Financial Results and Provides Business Update
Nov 2, 2020 08:00AM Lineage Cell Therapeutics to Host Expert Call Following OpRegen® Data Update at 2020 American Academy of Ophthalmology Meeting
Oct 28, 2020 08:00AM AgeX Therapeutics Sublicenses Stem Cell Line ESI-053 to ImStem Biotechnology for Development of Cell Therapy Candidate IMS001 for COVID-19 and Acute Respiratory Distress Syndrome
Oct 28, 2020 08:00AM Lineage Cell Therapeutics to Report Third Quarter 2020 Financial Results and Provide Business Update on November 4, 2020
Oct 15, 2020 08:00AM OpRegen Data Update to Be Featured in Presentation by Christopher D. Riemann, MD at 2020 American Academy of Ophthalmology Meeting
Oct 13, 2020 09:06AM Lineage Cell Therapeutics (LCTX) and Cancer Research UK Announce Encouraging Preliminary Phase 1 Study Results With VAC2 for the Treatment of Non-small Cell Lung Cancer
Oct 13, 2020 09:00AM Lineage Cell Therapeutics and Cancer Research UK Announce Encouraging Preliminary Phase 1 Study Results With VAC2 for the Treatment of Non-small Cell Lung Cancer
Sep 17, 2020 08:00AM Lineage Cell Therapeutics to Present at FORCE Wealth Virtual Fireside Chat on September 23, 2020
Sep 10, 2020 08:00AM Lineage Cell Therapeutics to Present at H.C. Wainwright 22nd Annual Global Investment Conference on September 14, 2020 and at Cantor Virtual Global Healthcare Conference on September 17, 2020
Sep 9, 2020 08:00AM AgeX Therapeutics and Lineage Cell Therapeutics Announce Expansion of Agreement Related to ESI Clinical-grade Pluripotent Stem Cell Lines for Therapeutic Purposes
Sep 9, 2020 08:00AM Lineage Cell Therapeutics and AgeX Therapeutics Announce Expansion of Agreement Related to ESI Clinical-Grade Pluripotent Stem Cell Lines for Therapeutic Purposes
Sep 8, 2020 08:00AM Lineage Cell Therapeutics Awarded Grant From Israel Innovation Authority for Development of a Bio-Retinal Patch for Treatment of Retinal Diseases in Partnership With Precise Bio
Aug 31, 2020 09:07AM Lineage Cell Therapeutics (LCTX) Receives $24.6 Million Payment From Juvenescence Ltd.
Aug 31, 2020 09:05AM Lineage Cell Therapeutics Receives $24.6 Million Payment From Juvenescence Ltd.
View More Recent Stories View Older Stories